Article Details

TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance ...

Retrieved on: 2022-09-26 08:37:17

Tags for this article:

Click the tags to see associated articles and topics

TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance .... View article details on HISWAI: https://www.yahoo.com/entertainment/tolerogenixx-publishes-three-data-phase-080000769.html

Excerpt

MIC cell treatment is a curative approach to achieve a sustained regulation of the immune system in transplant recipients and autoimmune patients.

Article found on: www.yahoo.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up